Richard L Schilsky
Biographic Data
| ID | 5539198 |
|---|---|
| NAME | Richard L Schilsky |
| GIVEN NAMES | Richard L |
| FAMILY NAME | Schilsky |
| SIGNATURE | SCHILSKY R L |
| AFFILIATIONS | University of Chicago |
| ORCID | 0000-0003-4474-4303 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2002 |
| LATEST PUBLICATION YEAR | 2008 |
| H-INDEX | 0 |
Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants
BACKGROUND: Because the elderly are underrepresented on clinical trials, physicians have few sources of information to estimate the risks (ie, toxicities) and benefits of chemotherapy administration to the elderly. OBJECTIVE: Our goal was to determine whether the standard measures of toxicity used in clinical trials could be captured from observational Medicare claims data. METHODS: We identified 175 elderly clinical trial patients treated on 2 C…
Construct Validity of Medicare Chemotherapy Claims
BACKGROUND: The elderly are under represented in clinical trials of cancer therapy and the elderly who are enrolled may be unrepresentative. OBJECTIVE: To assess whether Medicare claims data might be used to understand the benefits and tolerance of chemotherapy in the general elderly population, the construct validity of Medicare 5FU claims for elderly colon cancer patients within the SEER-Medicare data set was determined. METHODS: In this valida…
No prominent works on this page.
Construct Validity of Medicare Chemotherapy Claims
BACKGROUND: The elderly are under represented in clinical trials of cancer therapy and the elderly who are enrolled may be unrepresentative. OBJECTIVE: To assess whether Medicare claims data might be used to understand the benefits and tolerance of chemotherapy in the general elderly population, the construct validity of Medicare 5FU claims for elderly colon cancer patients within the SEER-Medicare data set was determined. METHODS: In this valida…
Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants
BACKGROUND: Because the elderly are underrepresented on clinical trials, physicians have few sources of information to estimate the risks (ie, toxicities) and benefits of chemotherapy administration to the elderly. OBJECTIVE: Our goal was to determine whether the standard measures of toxicity used in clinical trials could be captured from observational Medicare claims data. METHODS: We identified 175 elderly clinical trial patients treated on 2 C…
Medicine (2 works) · Actuarial science (1 work) · Business (1 work) · Cancer (1 work) · Cancer Treatment and Pharmacology (1 work) · Chemotherapy (1 work) · Clinical Psychology (1 work) · Colorectal Cancer Treatments and Studies (1 work) · Computer Science (1 work) · Construct (python library) (1 work)